Application of drug metabolism and pharmacokinetics for new drug development

New horizons in drug metabolism, pharmacokinetics and drug discovery.

Along with minimal toxicity, good drug metabolism and pharmacokinetic (DMPK) properties are essential for the clinical success of a drug candidate. A major cause of failure of orally administered drugs during their development is the discovery that in humans they have low intestinal absorption and/or high clearance causing low and variable bioavailability. In addition, drug interactions and the...

Role of pharmacokinetics and metabolism in drug discovery and development.

Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib.

Carfilzomib, an irreversible proteasome inhibitor, has a favorable safety profile and significant antitumor activity in patients with relapsed and refractory multiple myeloma (MM). Here we summarize the clinical pharmacokinetics (PK), metabolism, and drug-drug interaction (DDI) profile of carfilzomib. The PK of carfilzomib, infused over 2-10 minutes, was evaluated in patients with solid tumors ...

Advanced knowledge in drug metabolism and pharmacokinetics

Drug metabolism and transport in human organs, such as in the liver, intestine, and kidney, control the concentrations of a drug and its metabolites in the circulating system and target organs in a certain period of time following drug administration. The pharmacokinetic properties will consequently determine therapeutic efficacy and influence toxicological effects. Changes of drug metabolism a...

Application of Proteomics Technologies in the Drug Development Process